scholarly article | Q13442814 |
P50 | author | Ann Arvin | Q4766238 |
Marvin Sommer | Q104607360 | ||
P2093 | author name string | Hideki Ito | |
Shannon Taylor | |||
Jennifer Moffat | |||
P2860 | cites work | Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. | Q30657750 |
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse | Q34069075 | ||
The complete DNA sequence of varicella-zoster virus | Q34162480 | ||
Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice | Q35845405 | ||
Varicella-zoster virus glycoprotein I is essential for growth of virus in Vero cells. | Q35892356 | ||
The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse | Q36327713 | ||
Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system | Q36639428 | ||
Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization | Q36827734 | ||
Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking. | Q37900039 | ||
Trafficking of varicella-zoster virus glycoprotein gI: T(338)-dependent retention in the trans-Golgi network, secretion, and mannose 6-phosphate-inhibitable uptake of the ectodomain | Q39592132 | ||
Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument | Q39601211 | ||
Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. | Q39642417 | ||
Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail. | Q39879505 | ||
Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking | Q39882103 | ||
The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells | Q45729694 | ||
Intracellular transport of the glycoproteins gE and gI of the varicella-zoster virus. gE accelerates the maturation of gI and determines its accumulation in the trans-Golgi network | Q45756057 | ||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 4 | |
P304 | page(s) | 8468-8471 | |
P577 | publication date | 2002-08-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells | |
P478 | volume | 76 |
Q35956960 | Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I. |
Q45522159 | Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model |
Q34434777 | Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus |
Q37033241 | Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry |
Q37596465 | Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells |
Q28076882 | Dissecting the Molecular Mechanisms of the Tropism of Varicella-Zoster Virus for Human T Cells |
Q30832346 | Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection |
Q37378491 | Enhanced Viral Replication by Cellular Replicative Senescence |
Q35101360 | Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection |
Q37596576 | Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo |
Q33591823 | Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection |
Q28474768 | Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor |
Q37065966 | Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus. |
Q34648184 | Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. |
Q33791387 | Molecular mechanisms of varicella zoster virus pathogenesis |
Q37932527 | Molecular studies of the Oka varicella vaccine |
Q39846393 | Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo |
Q35076854 | Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells |
Q34977329 | Mutational Analysis of Open Reading Frames 62 and 71, Encoding the Varicella-Zoster Virus Immediate-Early Transactivating Protein, IE62, and Effects on Replication In Vitro and in Skin Xenografts in the SCID-hu Mouse In Vivo |
Q39698466 | Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo |
Q41877202 | Replication of varicella-zoster virus in human skin organ culture |
Q36136596 | Rodent models of varicella-zoster virus neurotropism |
Q33724286 | Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo |
Q40584589 | Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus |
Q59354332 | The C-terminus of varicella-zoster virus glycoprotein M contains trafficking motifs that mediate skin virulence in the SCID-human model of VZV pathogenesis |
Q35947774 | The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptor |
Q33554456 | The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection |
Q35785127 | The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo |
Q39214502 | Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis |
Q36474261 | Varicella-Zoster Virus ORF47 Protein Kinase, Which Is Required for Replication in Human T Cells, and ORF66 Protein Kinase, Which Is Expressed during Latency, Are Dispensable for Establishment of Latency |
Q33833934 | Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model |
Q45635208 | Varicella-Zoster virus proteins encoded by open reading frames 14 and 67 are both dispensable for the establishment of latency in a rat model |
Q34457924 | Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis |
Q34545651 | Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo |
Q41337775 | Varicella-zoster virus open reading frame 66 protein kinase is required for efficient viral growth in primary human corneal stromal fibroblast cells. |
Search more.